Evidence map›Paper›PMID 37068882›Full record

ReviewBiochemistry. Biokhimiia2023

Curative Potential of High-Value Phytochemicals on COVID-19 Infection.

Damodaran Sruthi, Menamadathil Dhanalakshmi, Hoovinakola Chinnappa Yashavantha Rao, Ramalingam Parthasarathy, Shashikala Paranthaman Deepanraj, Chelliah Jayabaskaran

Open access · bronzeAbstract readReview
In one paragraph

Review in Biochemistry. Biokhimiia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Exploring the Dynamics ofCurrent medicinal chemistry · 2025
    Article
  3. Review
  4. Dual Effects of 3-International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Damodaran SruthiDepartment of Biochemistry, Indian Institute of Science, Bengaluru, Karnataka, 560012, India. sruthi.skylarks@gmail.com.
Menamadathil DhanalakshmiResearch and Development Centre, Bharathiar University, Marudhamalai Road, Coimbatore, Tamil Nadu, 641046, India.
Hoovinakola Chinnappa Yashavantha RaoDepartment of Biochemistry, Indian Institute of Science, Bengaluru, Karnataka, 560012, India.
Ramalingam ParthasarathyDepartment of Biochemistry, Indian Institute of Science, Bengaluru, Karnataka, 560012, India.
Shashikala Paranthaman DeepanrajDepartment of Biological Sciences, Tata Institute for Genetics and Society, Instem building, National Centre for Biological Sciences Campus, Bengaluru, Karnataka, 560065, India.
Chelliah JayabaskaranDepartment of Biochemistry, Indian Institute of Science, Bengaluru, Karnataka, 560012, India.
Indian Institute of Science Bangalore · INBharathiar University · INTata Institute for Genetics and Society · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicinal plants and their therapeutically promising chemical compounds belonging to the valued category of 'traditional medicine' are potential remedies for various health problems. Due to their complex structure and enormous health benefits, the high-value plant-derived metabolites collectively termed as 'phytochemicals' have emerged as a crucial source for novel drug discovery and development. Indeed, several medicinal plants from diverse habitats are still in the 'underexplored' category in terms of their bioactive principles and therapeutic potential. COVID-19, infection caused by the SARS-CoV-2, first reported in November 2019, resulted in the alarming number of deaths (6.61 million), was further declared 'pandemic', and spread of the disease has continued till today. Even though the well-established scientific world has successfully implemented vaccines against COVID-19 within the short period of time, the focus on alternative remedies for long-term symptom management and immunity boosting have been increased. At this point, interventions based on traditional medicine, which include medicinal plants, their bioactive metabolites, extracts and formulations, attracted a lot of attention as alternative solutions for COVID-19 management. Here, we reviewed the recent research findings related to the effectiveness of phytochemicals in treatment or prevention of COVID-19. Furthermore, the literature regarding the mechanisms behind the preventive or therapeutic effects of these natural phytochemicals were also discussed. In conclusion, we suggest that the active plant-derived components could be used alone or in combination as an alternative solution for the management of SARS-CoV-2 infection. Moreover, the structure of these natural productomes may lead to the emergence of new prophylactic strategies for SARS-CoV-2-caused infection.

Indexed as

COVID-19Antiviral AgentsCOVID-19 VaccinesDrug DiscoveryHumansPhytochemicalsSARS-CoV-2Antiviral AgentsCOVID-19 VaccinesPhytochemicalsalkaloidsCOVID-19high-value phytochemicalsmedicinal plantsnatural productsphenolicsterpenoids

Identifiers

PMID37068882
PMCPMC9937517
OpenAlexW4321199950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.